These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19727541)
1. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541 [TBL] [Abstract][Full Text] [Related]
2. FDG-PET/CT findings of autoimmune pancreatitis. Kamisawa T; Takum K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K Hepatogastroenterology; 2010; 57(99-100):447-50. PubMed ID: 20698206 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings. Zhang J; Shao C; Wang J; Cheng C; Zuo C; Sun G; Cui B; Dong A; Liu Q; Kong L Abdom Imaging; 2013 Jun; 38(3):543-9. PubMed ID: 23223832 [TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study. Cheng MF; Guo YL; Yen RF; Chen YC; Ko CL; Tien YW; Liao WC; Liu CJ; Wu YW; Wang HP Sci Rep; 2018 Feb; 8(1):3651. PubMed ID: 29483544 [TBL] [Abstract][Full Text] [Related]
8. Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer. Ohtani M; Ofuji K; Akazawa Y; Saito Y; Nosaka T; Ozaki Y; Takahashi K; Naito T; Matsuda H; Hiramatsu K; Nakamoto Y Pancreas; 2021 Aug; 50(7):1014-1019. PubMed ID: 34629452 [TBL] [Abstract][Full Text] [Related]
9. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations. Santhosh S; Bhattacharya A; Harisankar CN; Kochhar R; Mittal BR Clin Nucl Med; 2013 Nov; 38(11):e423-5. PubMed ID: 23510878 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. Ozaki Y; Oguchi K; Hamano H; Arakura N; Muraki T; Kiyosawa K; Momose M; Kadoya M; Miyata K; Aizawa T; Kawa S J Gastroenterol; 2008; 43(2):144-51. PubMed ID: 18306988 [TBL] [Abstract][Full Text] [Related]
11. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Moon SH; Kim MH; Park DH; Hwang CY; Park SJ; Lee SS; Seo DW; Lee SK Gut; 2008 Dec; 57(12):1704-12. PubMed ID: 18583399 [TBL] [Abstract][Full Text] [Related]
12. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease. Nakajo M; Jinnouchi S; Noguchi M; Uozumi K; Tanabe H; Tateno R; Nakajo M Clin Nucl Med; 2007 Apr; 32(4):282-5. PubMed ID: 17413574 [TBL] [Abstract][Full Text] [Related]
13. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430 [TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis. Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028 [TBL] [Abstract][Full Text] [Related]
15. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis. Sato M; Okumura T; Shioyama Y; Imura J Ann Nucl Med; 2008 Apr; 22(3):215-9. PubMed ID: 18498037 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Imdahl A; Nitzsche E; Krautmann F; Högerle S; Boos S; Einert A; Sontheimer J; Farthmann EH Br J Surg; 1999 Feb; 86(2):194-9. PubMed ID: 10100786 [TBL] [Abstract][Full Text] [Related]
17. The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings. Shin JU; Lee JK; Kim KM; Lee KH; Lee KT; Kim YK; Lim JH; Jang KT Hepatogastroenterology; 2013; 60(125):1174-81. PubMed ID: 24298613 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis. Datta D; Selvakumar B; Goel AD; Chhibber S; Varshney VK; Kumar R Ann Nucl Med; 2024 Aug; 38(8):619-629. PubMed ID: 38750330 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Manfredi R; Graziani R; Cicero C; Frulloni L; Carbognin G; Mantovani W; Mucelli RP Radiology; 2008 May; 247(2):435-43. PubMed ID: 18430876 [TBL] [Abstract][Full Text] [Related]
20. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. Sun GF; Zuo CJ; Shao CW; Wang JH; Zhang J World J Gastroenterol; 2013 Jun; 19(23):3634-41. PubMed ID: 23801866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]